5,714 Shares in Astera Labs, Inc. $ALAB Bought by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,714 shares of the company’s stock, valued at approximately $2,760,000.

Several other institutional investors have also added to or reduced their stakes in the business. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs in the 4th quarter worth approximately $18,708,000. Swedbank AB boosted its stake in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in shares of Astera Labs during the fourth quarter valued at approximately $499,000. Revere Asset Management Inc bought a new position in shares of Astera Labs in the fourth quarter worth approximately $589,000. Finally, Banque Cantonale Vaudoise grew its holdings in shares of Astera Labs by 85.9% in the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock worth $766,000 after purchasing an additional 3,229 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the transaction, the director owned 3,970 shares in the company, valued at $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $284.97 on Monday. The business has a 50 day moving average of $352.70 and a 200 day moving average of $245.57. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market cap of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ALAB shares. Needham & Company LLC upped their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Stifel Nicolaus upped their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Finally, Barclays increased their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.